| Intracellular Proteins Displayed on the Surface of Tumor Cells as Targets for Therapeutic Intervention with Antibody-related Agents. U.H. WEIDLE, D. MAISEL, S. KLOSTERMANN, C. SCHILLER, E.H. WEISS (Penzberg; Munich, Germany). Cancer Genomics & Proteomics 8: 49-64, 2011. |
| Interleukin 6/Interleukin 6 Receptor Interaction and its Role as a Therapeutic Target for Treatment of Cachexia and Cancer. U.H. WEIDLE, S. KLOSTERMANN, D. EGGLE, A. KR?GER (Penzberg; Munich, Germany). Cancer Genomics & Proteomics 7: 287-302, 2010. |
| ALCAM/CD166: Cancer-related Issues. U.H. WEIDLE, D. EGGLE, S. KLOSTERMANN, G.W.M. SWART (Penzberg, Germany; Nijmegen, Netherlands). Cancer Genomics & Proteomics 7: 231-244, 2010. |
| TGF-â1 Interactome: Metastasis and Beyond. M. PERERA, C.S. TSANG, R.J. DISTEL, J.N. LACY, L. OHNO-MACHADO, V. RICCHIUTI, L.P. SAMARANAYAKE, G.B. SMEJKAL, M.G. SMITH, A.J. TRACHTENBERG, W.P. KUO (Hong Kong, Hong Kong; Boston, MA; Ormond Beach, FL; La Jolla, CA, USA). Cancer Genomics & Proteomics 7: 217-230, 2010. |
| Cancer-related Issues of CD147. U.H. WEIDLE, W. SCHEUER, D. EGGLE, S. KLOSTERMANN,H. STOCKINGER (Penzberg, Germany; Vienna, Austria). Cancer Genomics & Proteomics 7: 157-170, 2010. |
| The Role of Folate Metabolism-related Gene Polymorphisms in the Development of Meningiomas. S.S. DRAKOS, F. ANIFANTAKI, A. ZARROS, C. LIAPI (Athens, Greece). Cancer Genomics & Proteomics 7: 105-109, 2010. |
| Genetic Basis and Gene Therapy Trials for Thyroid Cancer. H. AL-HUMADI, A. ZARROS, R. ALSAIGH, C. LIAPI (Athens, Greece). Cancer Genomics & Proteomics 7: 31-50, 2010. |
| The Continuing Search For Predisposing Colorectal Cancer Variants. S. PICELLI, S. VON HOLST, P. WESSENDORF (Stockholm, Sweden). Cancer Genomics & Proteomics 6: 305-316, 2009. |
| Pathogenetic and Clinical Relevance of MicroRNAs in Colorectal Cancer. N. VALERI, C.M. CROCE, M. FABBRI (Columbus, OH, USA; Ferrara, Meldola, Italy). Cancer Genomics & Proteomics 6: 195-204, 2009. |
| Molecular Profiling for the Identification of New Biomarkers in Smokers and Cancer Patients. K. ALBERMANN, S. LANG, R. ZEIDLER (Essen; Munich, Germany). Cancer Genomics & Proteomics 4: 349-358, 2007. |
| Collagen ? A Necessary Accomplice in the Metastatic Process. P.S. NERENBERG, R. SALSAS-ESCAT, C.M. STULTZ (Cambridge, MA, USA). Cancer Genomics & Proteomics 4: 319-328, 2007. |
| Interpreting Microarray Data: Towards the Complete Bioinformatics Toolkit for Cancer. M.L. ROBERTS, S.D. KOTTARIDIS (Athens, Greece). Cancer Genomics & Proteomics 4: 301-308, 2007. |
Drug Transporters as Targets for Cancer Chemotherapy. T. NAKANISHI (Baltimore, MD, USA). Cancer Genomics & Proteomics 4: 241-254, 2007. |
| Molecular Targets in Metastasis: Lessons from Genomic Approaches. B. FINGLETON (Nashville, TN, USA). Cancer Genomics & Proteomics 4: 211-222, 2007. |
| Tailoring-targeted Therapy to Individual Patients: Lessons to be Learnt from the Development of Mitomycin C. M. VOLPATO, R.M. PHILLIPS (Bradford, UK). Cancer Genomics & Proteomics 4: 175-186, 2007. |
| 1 | 2 | 3 |
